These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36153306)

  • 1. Two is better than one: Effectiveness of dupilumab on atopic dermatitis and chronic rhinosinusitis with nasal polyps in an adolescent.
    Patruno C; Nocerino M; Maffei M; Menna L; Fornaro L; Fabbrocini G; Napolitano M
    Dermatol Ther; 2022 Nov; 35(11):e15857. PubMed ID: 36153306
    [No Abstract]   [Full Text] [Related]  

  • 2. Global influence of dupilumab on Quality of Life in a severe asthma patient with T2 multimorbidities: a case report on atopic dermatitis, chronic rhinosinusitis with nasal polyposis, and eosinophilic esophagitis.
    Colque-Bayona M; Hernández-Cano N; Tomás-Pérez M; Caballero T; Quirce S; Domínguez-Ortega J
    J Asthma; 2024 Jul; 61(7):762-765. PubMed ID: 38152869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
    Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis.
    Napolitano M; Maffei M; Patruno C; Leone CA; Di Guida A; Potestio L; Scalvenzi M; Fabbrocini G
    Dermatol Ther; 2021 Nov; 34(6):e15120. PubMed ID: 34472171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis.
    Chromy D; Bartosik T; Brkic FF; Quint T; Tu A; Eckl-Dorna J; Schneider S; Bangert C
    J Dermatol; 2023 Jan; 50(1):89-93. PubMed ID: 36177732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis.
    Boyle JV; Lam K; Han JK
    Immunotherapy; 2020 Feb; 12(2):111-121. PubMed ID: 32075470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps.
    van der Lans RJL; Fokkens WJ; Adriaensen GFJPM; Hoven DR; Drubbel JJ; Reitsma S
    Allergy; 2022 Feb; 77(2):670-674. PubMed ID: 34626497
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
    Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
    Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma.
    Bragança M; Pereira AM; Plácido JL; Amaral L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Jan; 141(1):55-56. PubMed ID: 37591762
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis.
    Aschenbrenner DS
    Am J Nurs; 2019 Oct; 119(10):21-22. PubMed ID: 31567245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies.
    Bachert C; Peters AT; Heffler E; Han JK; Olze H; Pfaar O; Chuang CC; Rout R; Attre R; Goga L; Jacob-Nara JA; Rowe PJ; Deniz Y; Chen Z; Kamat S; Siddiqui S
    Clin Exp Allergy; 2022 Feb; 52(2):244-249. PubMed ID: 35092110
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF-06817024 in Healthy Participants, Participants with Chronic Rhinosinusitis with Nasal Polyps, and Participants with Atopic Dermatitis: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study.
    Danto SI; Tsamandouras N; Reddy P; Gilbert S; Mancuso J; Page K; Peeva E; Vincent MS; Beebe JS
    J Clin Pharmacol; 2024 May; 64(5):529-543. PubMed ID: 37772436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic pulmonary complications of dupilumab in 2 patients with asthma and chronic rhinosinusitis with nasal polyps.
    Frohlich M; Olivenstein R; Cormier M
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):617-619. PubMed ID: 34929373
    [No Abstract]   [Full Text] [Related]  

  • 18. Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps.
    Hoy SM
    Drugs; 2020 May; 80(7):711-717. PubMed ID: 32240527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps.
    Hellings PW; Peters AT; Chaker AM; Heffler E; Zhang H; Praestgaard A; Nash S; Khan AH; Siddiqui S; Jacob-Nara JA; Rowe PJ; Deniz Y
    Int Forum Allergy Rhinol; 2022 Jul; 12(7):958-962. PubMed ID: 34911163
    [No Abstract]   [Full Text] [Related]  

  • 20. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.